GENETIC AND EPIGENETIC MECHANISMS IN THE PATHOGENESIS OF NEUROFIBROMATOSIS TYPE-I

被引:28
作者
METHENY, LJ
CAPPIONE, AJ
SKUSE, GR
机构
[1] UNIV ROCHESTER,MED CTR,DEPT MED,DIV GENET,ROCHESTER,NY 14642
[2] UNIV ROCHESTER,SCH MED & DENT,CTR CANC,ROCHESTER,NY 14642
关键词
EPIGENETIC GTPASE ACTIVATING PROTEIN; NERVOUS SYSTEM TUMORS; NEUROFIBROMATOSIS; PATHOGENESIS; POSTTRANSCRIPTIONAL MODIFICATION; TUMOR SUPPRESSOR;
D O I
10.1097/00005072-199511000-00001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurofibromatosis type I (NF1) is a common genetic disease which leads to a variety of clinical features affecting cells of neural crest origin. In the period since the NF1 gene was isolated in 1991, our understanding of the genetics of NF1 has increased remarkably. One of the most striking aspects of NF1 genetics is its complexity, both in terms of gene organization and expression. The gene is large and, when mutated, gives rise to diverse manifestations. A growing body of data suggests that mutations in the NF1 gene alone may not be responsible for all of the features of this disease. Epigenetic mechanisms, those which affect the NF1 transcript, play a role in the normal expression of the NF1 gene. Therefore, aberrations in those epigenetic processes are most likely pathogenic. Herein we summarize salient aspects of the vast body of NF1 literature and provide some insights into the myriad of regulatory mechanisms that may go awry in the genesis of this common but complex disease.
引用
收藏
页码:753 / 760
页数:8
相关论文
共 57 条
[1]  
AHLGRENBECKENDO.JA, 1993, BIOCHEM BIOPH RES CO, V197, P1019
[2]   3 DISTINCT RNA SEQUENCE ELEMENTS ARE REQUIRED FOR EFFICIENT APOLIPOPROTEIN-B (APO-B) RNA EDITING INVITRO [J].
BACKUS, JW ;
SMITH, HC .
NUCLEIC ACIDS RESEARCH, 1992, 20 (22) :6007-6014
[3]   THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS [J].
BALLESTER, R ;
MARCHUK, D ;
BOGUSKI, M ;
SAULINO, A ;
LETCHER, R ;
WIGLER, M ;
COLLINS, F .
CELL, 1990, 63 (04) :851-859
[4]   GENE FOR VON RECKLINGHAUSEN NEUROFIBROMATOSIS IS IN THE PERICENTROMERIC REGION OF CHROMOSOME-17 [J].
BARKER, D ;
WRIGHT, E ;
NGUYEN, K ;
CANNON, L ;
FAIN, P ;
GOLDGAR, D ;
BISHOP, DT ;
CAREY, J ;
BATY, B ;
KIVLIN, J ;
WILLARD, H ;
WAYE, JS ;
GREIG, G ;
LEINWAND, L ;
NAKAMURA, Y ;
OCONNELL, P ;
LEPPERT, M ;
LALOUEL, JM ;
WHITE, R ;
SKOLNICK, M .
SCIENCE, 1987, 236 (4805) :1100-1102
[5]  
BASS BL, 1993, RNA WORLD
[6]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[7]  
BAUM CL, 1990, J BIOL CHEM, V265, P19263
[8]   CHIMERIC GRNA MESSENGER-RNA MOLECULES WITH OLIGO(U) TAILS COVALENTLY LINKED AT SITES OF RNA EDITING SUGGEST THAT U-ADDITION OCCURS BY TRANSESTERIFICATION [J].
BLUM, B ;
STURM, NR ;
SIMPSON, AM ;
SIMPSON, L .
CELL, 1991, 65 (04) :543-550
[9]   CHARACTERIZATION OF FULL-LENGTH NEUROFIBROMIN - TUBULIN INHIBITS RAS GAP ACTIVITY [J].
BOLLAG, G ;
MCCORMICK, F ;
CLARK, R .
EMBO JOURNAL, 1993, 12 (05) :1923-1927
[10]   TARGETED DISRUPTION OF THE NEUROFIBROMATOSIS TYPE-1 GENE LEADS TO DEVELOPMENTAL ABNORMALITIES IN HEART AND VARIOUS NEURAL CREST-DERIVED TISSUES [J].
BRANNAN, CI ;
PERKINS, AS ;
VOGEL, KS ;
RATNER, N ;
NORDLUND, ML ;
REID, SW ;
BUCHBERG, AM ;
JENKINS, NA ;
PARADA, LF ;
COPELAND, NG .
GENES & DEVELOPMENT, 1994, 8 (09) :1019-1029